Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Prostatectomy Outcomes
Prostatectomy ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s prostatectomy ACS NSQIP performance benchmarked against 119 participating sites.
| Prostatectomy (119 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 253 | 3.16% | 4.14% |
| Cardiac | 253 | 0.40% | 0.23% |
| Pneumonia | 253 | 0.40% | 0.24% |
| Unplanned Intubation | 253 | 0.00% | 0.06% |
| Renal Failure | 253 | 0.00% | 0.20% |
| Urinary Tract Infection (UTI) | 253 | 1.58% | 2.48% |
| Surgical Site Infection (SSI) | 253 | 1.19% | 1.68% |
| Sepsis | 253 | 1.19% | 0.53% |
| Unplanned Readmission | 253 | 7.11% | 3.29% |
| Anastomotic Leak | 253 | 0.79% | 0.39% |
| Prolonged NPO/NGT Use | 253 | 1.58% | 0.56% |
| Ureteral Obstruction | 253 | 0.00% | 0.24% |
| Urinary Leak/Fistula | 253 | 0.00% | 0.80% |
| Lymphocele/Leak/Fluid | 253 | 0.79% | 1.28% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
